Leukemia & Lymphoma, Volume 56, Issue 3 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 3 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary on selected article in this issue

Article Commentary
Appraising myc involvement in high risk myeloma
Efstathios Kastritis & Meletios A. Dimopoulos
Pages: 551-552
Published online: 05 Nov 2014
CitationforAppraising myc involvement in high risk myeloma | Full Text | References | PDF (88.8 KB) | Supplemental
  • 931 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article Commentary
Bisphosphonates in multiple myeloma: a fractured consensus
Shaji K. Kumar
Pages: 553-554
Published online: 05 Nov 2014
CitationforBisphosphonates in multiple myeloma: a fractured consensus | Full Text | References | PDF (85.2 KB) | Supplemental
  • 941 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article Commentary
Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?
Basem M. William & Marcos de Lima
Pages: 555-556
Published online: 20 Aug 2014
CitationforSirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better? | Full Text | References | PDF (85.3 KB) | Supplemental
  • 553 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article Commentary
Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era
Christopher R. Flowers, Jonathon B. Cohen & Mohammad K. Khan
Pages: 557-558
Published online: 19 Nov 2014
CitationforRebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era | Full Text | References | PDF (89.7 KB) | Supplemental
  • 1157 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Bendamustine for the treatment of multiple myeloma in first-line and relapsed–refractory settings: a review of clinical trial data
Antonio Palumbo, Massimo Offidani, Francesca Patriarca, Maria Teresa Petrucci & Michele Cavo
Pages: 559-567
Published online: 27 Jun 2014
AbstractforBendamustine for the treatment of multiple myeloma in first-line and relapsed–refractory settings: a review of clinical trial data | Full Text | References | PDF (311.5 KB) | Supplemental
  • 1084 Views
  • 10 CrossRef citations
  • 0Altmetric
Review Article
Outcomes of chronic-phase chronic myeloid leukemia beyond first-line therapy
Hanna J. Khoury & Dale L. Bixby
Pages: 568-576
Published online: 23 Jul 2014
AbstractforOutcomes of chronic-phase chronic myeloid leukemia beyond first-line therapy | Full Text | References | PDF (208.5 KB) | Supplemental
  • 685 Views
  • 3 CrossRef citations
  • 0Altmetric
Review Article
Src family kinases and their role in hematological malignancies
Matthew Ku, Meaghan Wall, Ruth N. MacKinnon, Carl R. Walkley, Louise E. Purton, Constantine Tam, David Izon, Lynda Campbell, Heung-Chin Cheng & Harshal Nandurkar
Pages: 577-586
Published online: 21 Jan 2015
AbstractforSrc family kinases and their role in hematological malignancies | Full Text | References | PDF (704.1 KB) | Supplemental
  • 652 Views
  • 18 CrossRef citations
  • 0Altmetric

Clinical Dilemma

How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
Constantine S. Tam & Stephan Stilgenbauer
Pages: 587-593
Published online: 17 Feb 2015
AbstractforHow best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation? | Full Text | References | PDF (147.1 KB) | Supplemental
  • 955 Views
  • 13 CrossRef citations
  • 0Altmetric

Original Article: Clinical

A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue
Ping Wu, Brian A. Walker, Annemiek Broyl, Martin Kaiser, David C. Johnson, Rowan Kuiper, Mark van Duin, Walter M. Gregory, Faith E. Davies, Daniel Brewer, Dirk Hose, Pieter Sonneveld & Gareth J. Morgan
Pages: 594-601
Published online: 19 Aug 2014
AbstractforA gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue | Full Text | References | PDF (2.2 MB) | Supplemental
  • 1199 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma
Isabella C. Glitza, Gary Lu, Rupin Shah, Qaiser Bashir, Nina Shah, Richard E. Champlin, Jatin Shah, Robert Z. Orlowski & Muzaffar H. Qazilbash
Pages: 602-607
Published online: 18 Aug 2014
AbstractforChromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma | Full Text | References | PDF (723.3 KB) | Supplemental
  • 552 Views
  • 33 CrossRef citations
  • 0Altmetric
Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial)
Andrea Schmid, Dorothea Friess, Behrouz Mansouri Taleghani, Peter Keller, Beatrice U. Mueller, Gabriela M. Baerlocher, Kurt Leibundgut & Thomas Pabst
Pages: 608-614
Published online: 04 Aug 2014
AbstractforRole of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial) | Full Text | References | PDF (173.5 KB) | Supplemental
  • 259 Views
  • 14 CrossRef citations
  • 0Altmetric
Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma
K. M. Sanfilippo, B. Gage, S. Luo, K. Weilbaecher, M. Tomasson, R. Vij, G. Colditz & K. Carson
Pages: 615-621
Published online: 14 Jul 2014
AbstractforComparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma | Full Text | References | PDF (475.9 KB) | Supplemental
  • 529 Views
  • 29 CrossRef citations
  • 0Altmetric
Higher percentage of CD34 + CD38− cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia
Adriana Plesa, Mohamed Elhamri, Gilles Clapisson, Eve Mattei, Sophie Gazzo, Olivier Hequet, Isabelle Tigaud, Mauricette Michallet, Charles Dumontet & Xavier Thomas
Pages: 622-629
Published online: 17 Jul 2014
AbstractforHigher percentage of CD34 + CD38− cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia | Full Text | References | PDF (1.4 MB) | Supplemental
  • 258 Views
  • 8 CrossRef citations
  • 0Altmetric
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial
Jason D. Lickliter, Kerry Taylor, Jeff Szer, Andrew Grigg, Christopher Arthur, Timothy P. Hughes, Simon Durrant, Robin Filshie, Ian Irving, Michael Seldon, Jennifer Ellacott, Andrew W. Boyd, James D’Rozario, Kim Rooney, Kevin Lynch, Ken Bradstock & for the Australasian Leukaemia and Lymphoma Group
Pages: 630-638
Published online: 04 Aug 2014
AbstractforAn imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial | Full Text | References | PDF (589.2 KB) | Supplemental
  • 299 Views
  • 2 CrossRef citations
  • 0Altmetric
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significance
Anna Flammiger, Ulrike Bacher, Maximilian Christopeit, Christiane Horn, Elke Rühlmann, Katrin Kluge, Eik Vettorazzi, Carsten Bokemeyer & Mascha Binder
Pages: 639-644
Published online: 04 Aug 2014
AbstractforMultiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significance | Full Text | References | PDF (684.6 KB) | Supplemental
  • 364 Views
  • 6 CrossRef citations
  • 0Altmetric
Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
Luciano J. Costa, Suzanne R. Fanning, Joe Stephenson Jr, Lawrence B. Afrin, Emily Kistner-Griffin, Tricia A. Bentz & Robert K. Stuart
Pages: 645-649
Published online: 17 Aug 2014
AbstractforSequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma | Full Text | References | PDF (191 KB) | Supplemental
  • 672 Views
  • 21 CrossRef citations
  • 0Altmetric
Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study
Rosanna Parasole, Fara Petruzziello, Chiara Messina, Elena Barisone, Andrea Pession, Franco Locatelli, Concetta Micalizzi, Simone Cesaro, Anna Maria Testi, Antonia De Matteo, Stefania Varotto, Massimo Berger, William Morello, Giuseppe Menna & Vincenzo Poggi
Pages: 650-655
Published online: 04 Aug 2014
AbstractforToxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study | Full Text | References | PDF (236.7 KB) | Supplemental
  • 532 Views
  • 8 CrossRef citations
  • 0Altmetric
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients
Christelle Ferrà, Jaime Sanz, Miguel-Angel Díaz-Pérez, Mireia Morgades, Jorge Gayoso, José-Rafael Cabrera, Teresa Villaescusa, María-Antonia Sampol, Francesc Fernández-Avilés, Carlos Solano, Miguel Ortín, Rafael Duarte, Marian Cuesta, Inmaculada Heras, Javier de la Serna, José-María Moraleda, Cristina Barrenetxea, Marta González-Vicent, Guillermo Sanz, Josep-Maria Ribera & for the Grupo Español de Trasplante Hematopoyético (Geth) Spanish Society of Hematology
Pages: 656-662
Published online: 04 Aug 2014
AbstractforOutcome of graft failure after allogeneic stem cell transplant: study of 89 patients | Full Text | References | PDF (187 KB) | Supplemental
  • 766 Views
  • 28 CrossRef citations
  • 0Altmetric
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant
Izaskun Ceberio, Sean M. Devlin, Craig Sauter, Juliet N. Barker, Hugo Castro-Malaspina, Sergio Giralt, Doris M. Ponce, Lauren Lechner, Molly A. Maloy, Jenna D. Goldberg & Miguel-Angel Perales
Pages: 663-670
Published online: 06 Aug 2014
AbstractforSirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant | Full Text | References | PDF (313.9 KB) | Supplemental
  • 288 Views
  • 18 CrossRef citations
  • 0Altmetric
Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection
Katrin Lorenz, Katharina Rommel, Jiju Mani, Nan Jin, Inken Hilgendorf, Anthony D. Ho, Mathias Freund, Michael Schmitt & Anita Schmitt
Pages: 671-675
Published online: 09 Jul 2014
AbstractforModulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection | Full Text | References | PDF (664.1 KB) | Supplemental
  • 467 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
The significance of single nucleotide polymorphism rs2070770 in CD20 gene in Chinese patients with diffuse large B-cell lymphoma
Li-Na Zhang, Li Wang, Cheng Fang, Zhi-Jian Zou, Lei Fan, Run Zhang, Ken H. Young, Jian-Yong Li & Wei Xu
Pages: 676-681
Published online: 17 Jul 2014
AbstractforThe significance of single nucleotide polymorphism rs2070770 in CD20 gene in Chinese patients with diffuse large B-cell lymphoma | Full Text | References | PDF (1,000.5 KB) | Supplemental
  • 118 Views
  • 5 CrossRef citations
  • 0Altmetric
The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma
Huei-Ting Tsai, Ruth M. Pfeiffer, Joan Warren, Wyndham Wilson & Ola Landgren
Pages: 682-687
Published online: 15 Jul 2014
AbstractforThe effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma | Full Text | References | PDF (194.1 KB) | Supplemental
  • 398 Views
  • 12 CrossRef citations
  • 0Altmetric
Prognostic impact of β2-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma
Changhoon Yoo, Dok Hyun Yoon, Shinkyo Yoon, Shin Kim, Jooryung Huh, Chan-Jeong Park, Sang-Wook Lee & Cheolwon Suh
Pages: 688-693
Published online: 17 Jul 2014
AbstractforPrognostic impact of β2-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma | Full Text | References | PDF (286 KB) | Supplemental
  • 218 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006–2009
Christian Schmidt, Guenter Fingerle-Rowson, Angelika Boehme, Kurt Brendel, Richard Fischer, Michael Gonnermann, Thomas Höhler, Thomas Kegel, Lenka Kellermann, Arndt Nusch, Wolfram Pönisch, Clemens Wendtner & Martin Dreyling
Pages: 694-702
Published online: 19 Aug 2014
AbstractforChanges in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006–2009 | Full Text | References | PDF (664.3 KB) | Supplemental
  • 267 Views
  • 5 CrossRef citations
  • 0Altmetric
Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Tim Illidge, Reda Bouabdallah, Robert Chen, Ajay K. Gopal, Craig H. Moskowitz, Radhakrishnan Ramchandren, Andrei R. Shustov, Herve Tilly, Tanya M. Trippett, Adam Gibb, Laurie E. Grove & Ranjana Advani
Pages: 703-710
Published online: 21 Jan 2015
AbstractforAllogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma | Full Text | References | PDF (696.8 KB) | Supplemental
  • 1244 Views
  • 25 CrossRef citations
  • 0Altmetric
Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis
Michelle L. Poon, Patricia S. Fox, Barry I. Samuels, Susan O’Brien, Elias Jabbour, Yvonne Hsu, Alison Gulbis, Martin Korbling, Richard Champlin, Lynne V. Abruzzo, Roland L. Bassett & Issa F. Khouri
Pages: 711-715
Published online: 04 Aug 2014
AbstractforAllogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis | Full Text | References | PDF (399.7 KB) | Supplemental
  • 275 Views
  • 15 CrossRef citations
  • 0Altmetric
Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients
Oreofe O. Odejide, Angel M. Cronin, Amy J. Davidoff, Ann S. LaCasce & Gregory A. Abel
Pages: 716-724
Published online: 06 Aug 2014
AbstractforLimited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients | Full Text | References | PDF (307.7 KB) | Supplemental
  • 847 Views
  • 34 CrossRef citations
  • 0Altmetric
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone
Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, Kumiko Kishimoto, Daisuke Ishibashi, Satoshi Koyama, Yoshimi Ishii, Hiroyuki Takahashi, Ayumi Numata, Reina Watanabe, Takayoshi Tachibana, Rika Ohshima, Maki Hagihara, Chizuko Hashimoto, Sachiya Takemura, Jun Taguchi, Katsumichi Fujimaki, Rika Sakai, Shigeki Motomura & Yoshiaki Ishigatsubo
Pages: 725-729
Published online: 06 Aug 2014
AbstractforIntrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone | Full Text | References | PDF (211.8 KB) | Supplemental
  • 980 Views
  • 19 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells
Yuqing Ge, Bo Yang, Xiaofeng Xu, Qun Dai, Zhe Chen & Rubin Cheng
Pages: 730-738
Published online: 25 Jun 2014
AbstractforCryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells | Full Text | References | PDF (2.1 MB) | Supplemental
  • 268 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage
Cecilia Savorani, Valentina Manfé, Edyta Biskup & Robert Gniadecki
Pages: 739-747
Published online: 04 Aug 2014
AbstractforEllipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage | Full Text | References | PDF (987.1 KB) | Supplemental
  • 194 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Functional p53 can modulate the relationship between E2F-1 expression and tumor kinetics in Hodgkin lymphoma
Eleni C. Georgiadi, Georgios S. Dimtsas, Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Christos Kittas & Ipatia A. Doussis-Anagnostopoulou
Pages: 748-754
Published online: 06 Aug 2014
AbstractforFunctional p53 can modulate the relationship between E2F-1 expression and tumor kinetics in Hodgkin lymphoma | Full Text | References | PDF (494.5 KB) | Supplemental
  • 137 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
The Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells
Chenjiao Yao, Wei Du, Haibing Chen, Sheng Xiao, Lihua Huang & Fangping Chen
Pages: 755-762
Published online: 18 Aug 2014
AbstractforThe Fanconi anemia/BRCA pathway is involved in DNA interstrand cross-link repair of adriamycin-resistant leukemia cells | Full Text | References | PDF (1,020.8 KB) | Supplemental
  • 252 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
No association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjects
Jing He, Fang Wang, Jin-Hong Zhu, Wei Chen, Zhuo Cui & Wei-Hua Jia
Pages: 763-767
Published online: 13 Aug 2014
AbstractforNo association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjects | Full Text | References | PDF (271.6 KB) | Supplemental
  • 136 Views
  • 8 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Imatinib non-responsive chronic eosinophilic leukemia with ETV6–PDGFRA fusion gene
Masahiro Yoshida, Nobuyoshi Tamagawa, Takafumi Nakao, Hiroshi Kanashima, Hideya Ueda, Akiko Murakami, Toru Yorifuji & Takahisa Yamane
Pages: 768-769
Published online: 18 Aug 2014
CitationforImatinib non-responsive chronic eosinophilic leukemia with ETV6–PDGFRA fusion gene | Full Text | References | PDF (817 KB) | Supplemental
  • 282 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study
Sara Bigliardi, Monica Morselli, Leonardo Potenza, Valeria Coluccio, Monica Maccaferri, Ambra Paolini, Elisabetta Colaci, Valeria Fantuzzi, Laura Faglioni, Francesco Soci, Vincenzo Nasillo, Andrea Messerotti, Paola Pedrazzi, Marco Marietta, Mario Luppi & Fabio Forghieri
Pages: 770-773
Published online: 04 Aug 2014
First Page PreviewforSafety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study | Full Text | References | PDF (110.4 KB) | Supplemental
  • 221 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Development of T-cell lymphomas with an activated cytotoxic immunophenotype, including anaplastic large cell lymphomas, in patients with chronic lymphocytic leukemia: a series of six cases
Sarah Mant, Graeme Taylor, David Dutton, Andrew Butler, Peter Browett & Peter Ganly
Pages: 774-778
Published online: 17 Jul 2014
First Page PreviewforDevelopment of T-cell lymphomas with an activated cytotoxic immunophenotype, including anaplastic large cell lymphomas, in patients with chronic lymphocytic leukemia: a series of six cases | Full Text | References | PDF (104 KB) | Supplemental
  • 146 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab
Robert C. Quackenbush, Thierry J. Horner, Vanessa C. Williams, Patricia Giampietro & Thomas S. Lin
Pages: 779-781
Published online: 23 Jul 2014
First Page PreviewforPatients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab | Full Text | References | PDF (117 KB) | Supplemental
  • 302 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia
Masumi Ueda, Hu Xie, Ravinder K. Sandhu, Roland B. Walter, John M. Pagel & Elihu H. Estey
Pages: 782-784
Published online: 17 Jul 2014
First Page PreviewforFactors associated with early reinduction chemotherapy for adults with acute myeloid leukemia | Full Text | References | PDF (124.6 KB) | Supplemental
  • 128 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma
Saori Maegawa, Junya Kuroda, Tsutomu Kobayashi, Shinichi Fuchida, Eri Kawata, Yuri Kamitsuji, Yasuhiko Tsutsumi, Toshiki Iwai, Mitsushige Nakao, Hiroto Kaneko, Nobuhiko Uoshima, Chihiro Shimazaki, Yutaka Kobayashi, Shigeo Horiike, Aihiro Yamamoto, Yutaka Kawahito & Masafumi Taniwaki
Pages: 785-788
Published online: 25 Jun 2014
First Page PreviewforClinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma | Full Text | References | PDF (398.4 KB) | Supplemental
  • 229 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Translocation (18;22)(q21;q11.2) in B-cell lymphoproliferative disorders: a report of six cases
Perla Britos-Franco, Ines Rodríguez-Hernández, José-Tomás Navarro, Isabel Granada, Gustavo Tapia, Jordi Juncà, Josep-Maria Ribera & Fuensanta Millá
Pages: 789-792
Published online: 17 Jul 2014
First Page PreviewforTranslocation (18;22)(q21;q11.2) in B-cell lymphoproliferative disorders: a report of six cases | Full Text | References | PDF (185.7 KB) | Supplemental
  • 66 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL–FNBP1 fusion gene
Manuela Krumbholz, Ronny Jung, Jutta Bradtke, Dirk Reinhardt, Daniel Stachel & Markus Metzler
Pages: 793-796
Published online: 17 Jul 2014
First Page PreviewforResponse monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL–FNBP1 fusion gene | Full Text | References | PDF (1.6 MB) | Supplemental
  • 164 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Alternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma
Judy P. Tsai, Wade T. Iams, John P. Greer, David S. Morgan, Shaoying Li & Nishitha M. Reddy
Pages: 797-800
Published online: 17 Jul 2014
First Page PreviewforAlternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma | Full Text | References | PDF (223.4 KB) | Supplemental
  • 149 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study
Massimo Martino, Letteria Russo, Tiziana Martinello, Giuseppe Alberto Gallo, Roberta Fedele, Tiziana Moscato, Giuseppe Console, Donatella Iolanda Vincelli, Francesca Ronco, Maurizio Postorino, Giuseppe Irrera & Giuseppe Messina
Pages: 801-804
Published online: 17 Jul 2014
First Page PreviewforA home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study | Full Text | References | PDF (106.3 KB) | Supplemental
  • 226 Views
  • 16 CrossRef citations
  • 0Altmetric
Letter
Recurrent and partially reversible cardiomyopathy occurring during treatment with bendamustine and rituximab
Sudhanshu Mulay & Adam Boruchov
Pages: 805-807
Published online: 03 Jul 2014
First Page PreviewforRecurrent and partially reversible cardiomyopathy occurring during treatment with bendamustine and rituximab | Full Text | References | PDF (257.6 KB) | Supplemental
  • 445 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Cereblon expression predicts clinical response in chronic lymphocytic leukemia treated with a thalidomide/fludarabine regimen
Krzysztof Jamroziak, Janusz Szemraj, Tadeusz Robak, Andrzej Tukiendorf & Krzysztof Giannopoulos
Pages: 808-810
Published online: 17 Jul 2014
First Page PreviewforCereblon expression predicts clinical response in chronic lymphocytic leukemia treated with a thalidomide/fludarabine regimen | Full Text | References | PDF (169.9 KB) | Supplemental
  • 329 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Spontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia
Fayez Estephan, Heesun J. Rogers, Valeria Visconte, Ali Tabarroki, Jing Ai, Hien K. Duong, Matt Kalaycio & Ramon V. Tiu
Pages: 811-813
Published online: 17 Jul 2014
First Page PreviewforSpontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia | Full Text | References | PDF (1.6 MB) | Supplemental
  • 204 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin–Frankfurt–Münster Study Group
Thies Bartram, Birgit Burkhardt, Wilhelm Wössmann, Kathrin Seidemann, Martin Zimmermann, Gunnar Cario, Jasmin Lisfeld, Eva Ellinghaus, Andre Franke, Richard S. Houlston, Martin Schrappe, Alfred Reiter & Martin Stanulla
Pages: 814-816
Published online: 13 Aug 2014
First Page PreviewforChildhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin–Frankfurt–Münster Study Group | Full Text | References | PDF (118.8 KB) | Supplemental
  • 330 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Achievement of morphologic and cytogenetic remission with single-agent hydroxyurea in a patient with acute myeloid leukemia with inv(16)
Ami B. Patel, Yi-Hua Chen, Yanming Zhang, Olga Frankfurt & Jane N. Winter
Pages: 817-819
Published online: 13 Aug 2014
First Page PreviewforAchievement of morphologic and cytogenetic remission with single-agent hydroxyurea in a patient with acute myeloid leukemia with inv(16) | Full Text | References | PDF (411.4 KB) | Supplemental
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia
Hongjie Shen, Hongying Chao, Zixuan Ding, Yufeng Feng, Jiannong Cen, Jinlan Pan, Jun He, Ming Zhou, Zixing Chen & Suning Chen
Pages: 820-822
Published online: 13 Aug 2014
First Page PreviewforCALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia | Full Text | References | PDF (165 KB) | Supplemental
  • 407 Views
  • 13 CrossRef citations
  • 0Altmetric
Letter
Second hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene
Kalman Filanovsky, Rinat Yacobi, Eliakim Vorst, Iris Barshack, Eva Ustaev, Edit Feldberg & Lev Shvidel
Pages: 823-825
Published online: 20 Aug 2014
First Page PreviewforSecond hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene | Full Text | References | PDF (897 KB) | Supplemental
  • 156 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation
Nicoletta Coccaro, Giuseppina Tota, Luisa Anelli, Antonella Zagaria, Paola Casieri, Angelo Cellamare, Angela Minervini, Crescenzio Francesco Minervini, Claudia Brunetti, Alessandra Ricco, Paola Orsini, Cosimo Cumbo, Giorgina Specchia & Francesco Albano
Pages: 826-828
Published online: 04 Aug 2014
First Page PreviewforCentromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation | Full Text | References | PDF (452.8 KB) | Supplemental
  • 114 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Hyperhemolysis associated with marginal zone lymphoma
Matthew Yan, Jeannie Callum & Yulia Lin
Pages: 829-831
Published online: 04 Aug 2014
First Page PreviewforHyperhemolysis associated with marginal zone lymphoma | Full Text | References | PDF (139.7 KB) | Supplemental
  • 160 Views
  • 4 CrossRef citations
  • 0Altmetric

Correspondence

Letter
CD30 in pediatric post-transplant lymphoproliferative disease after solid organ transplant: characterization of a new therapeutic target
Tilmann Schober, Theodor Framke, Anika Großhennig, Christoph Klein, Hans Kreipe & Britta Maecker-Kolhoff
Pages: 832-833
Published online: 03 Nov 2014
CitationforCD30 in pediatric post-transplant lymphoproliferative disease after solid organ transplant: characterization of a new therapeutic target | Full Text | References | PDF (91.9 KB) | Supplemental
  • 165 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles